231 results on '"Lim, Joseph K."'
Search Results
2. An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis
3. Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents
4. Management of HBV reactivation: Challenges and opportunities
5. Clinical Liver Disease: Legacy of innovation in hepatology education
6. 1026. Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody after Switching to Antiretroviral Therapy without Hepatitis B Activity
7. Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims Database
8. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
9. Hepatitis C in Black Individuals in the US
10. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
11. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
12. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
13. Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention
14. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review
15. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
16. Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
17. Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV
18. Percutaneous decannulation of venoarterial extracorporeal membrane oxygenation using the Manta vascular closure device: A systematic review and meta‐analysis
19. Drug-Induced Liver Injury
20. Lean NAFLD is associated with adverse liver events and mortality: moving beyond BMI
21. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
22. Reply
23. The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
24. Chronic Hepatitis B Virus: What an Internist Needs to Know
25. Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012–2019
26. Tailoring stepwise treatment for Budd-Chiari syndrome: insights from the Asian Pacific Association for the Study of the Liver (APASL) consensus guidance
27. Left Atrial Mechanics and Diastolic Function Among People Living With Human Immunodeficiency Virus (from the Veterans Aging Cohort Study)
28. Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination
29. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment
30. Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
31. Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
32. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
33. Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak
34. Su1343: INCREASED COMORBIDITY BURDEN AMONG HDV INFECTION VERSUS HBV MONOINFECTION AMONG COMMERCIALLY INSURED ADULTS IN THE UNITED STATES: AN ALL-PAYER CLAIMS DATABASE ANALYSIS
35. Su1368: ADVANCED LIVER FIBROSIS AND OBESITY ARE PRIMARY RISK FACTORS FOR LONG-TERM OUTCOMES IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
36. 871: HEPATITIS DELTA AMONG COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES: AN ANALYSIS OF PREVALENCE, PATIENT CHARACTERISTICS, AND SOCIOECONOMIC STATUS
37. The ALT upper reference interval debate: Blame it on the alcohol
38. NASH and the Gut Microbiome: Implications for New Therapies
39. Oral Cyanobacteria and Hepatocellular Carcinoma
40. Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
41. Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study
42. Care of the Patient With Abnormal Liver Test Results
43. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update
44. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
45. Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study
46. LEFT ATRIAL STRAIN AND DIASTOLIC DYSFUNCTION AMONGST HIV-POSITIVE INDIVIDUALS: INSIGHTS FROM THE VETERANS AGING COHORT STUDY
47. Willingness to participate in research among black patients with liver disease: A national cross‐sectional study
48. AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
49. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
50. Patient‐reported outcomes 12 months after hepatitis C treatment with direct‐acting antivirals: Results from the PROP UP study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.